Nicolas A. Menzies, Ph.D.
Affiliations: | 2014 | Health Policy | Harvard University, Cambridge, MA, United States |
Area:
Public Health, Epidemiology, General EconomicsGoogle:
"Nicolas Menzies"Cross-listing: PHTree
Parents
Sign in to add mentorJoshua A. Salomon | grad student | 2014 | Harvard | |
(Mathematical Modeling to Evaluate Disease Control Policy.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Sinha P, Dauphinais M, Carwile ME, et al. (2024) In-kind nutritional supplementation for household contacts of persons with tuberculosis would be cost-effective for reducing tuberculosis incidence and mortality in India: a modeling study. Medrxiv : the Preprint Server For Health Sciences |
Regan M, Li Y, Swartwood NA, et al. (2024) Racial and ethnic disparities in diagnosis and treatment outcomes among US-born people diagnosed with tuberculosis, 2003-19: an analysis of national surveillance data. The Lancet. Public Health. 9: e47-e56 |
Ekramnia M, Li Y, Haddad MB, et al. (2023) Estimated rates of progression to tuberculosis disease for persons infected with Mycobacterium tuberculosis in the United States. Epidemiology (Cambridge, Mass.). 35: 164-173 |
Havumaki J, Warren JL, Zelner J, et al. (2023) Spatially-targeted tuberculosis screening has limited impact beyond household contact tracing in Lima, Peru: A model-based analysis. Plos One. 18: e0293519 |
Clark RA, Portnoy A, Weerasuriya CK, et al. (2023) The potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study. Medrxiv : the Preprint Server For Health Sciences |
Menzies NA, Allwood BW, Dean AS, et al. (2023) Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis. Nature Communications. 14: 6182 |
Portnoy A, Yamanaka T, Nguhiu P, et al. (2023) Costs incurred by people receiving tuberculosis treatment in low-income and middle-income countries: a meta-regression analysis. The Lancet. Global Health. 11: e1640-e1647 |
Swartwood NA, Testa C, Cohen T, et al. (2023) Tabby2: a user-friendly web tool for forecasting state-level TB outcomes in the United States. Bmc Medicine. 21: 331 |
Klaassen F, Chitwood MH, Cohen T, et al. (2023) Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
Rönn MM, Menzies NA, Salomon JA. (2023) Vaccination and voting patterns in the United States: analysis of COVID-19 and flu surveys from 2010 to 2022. American Journal of Preventive Medicine |